Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study
|ClinicalTrials.gov Identifier: NCT00921687|
Recruitment Status : Completed
First Posted : June 16, 2009
Results First Posted : May 23, 2013
Last Update Posted : May 27, 2013
|Condition or disease||Intervention/treatment|
|Chronic Renal Insufficiency||Behavioral: Education only Behavioral: Multifactorial intervention|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||781 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||Chronic Kidney Disease Guideline Adherence - a Cluster Randomized Controlled Quality Improvement Study|
|Study Start Date :||July 2009|
|Primary Completion Date :||June 2010|
|Study Completion Date :||June 2010|
Experimental: Multifactorial intervention
The multifactorial intervention will consist of a CKD lecture, the CKD reference card, academic detailing, and access to the CKD registry.
Behavioral: Multifactorial intervention
Providers in the intervention group will receive a lecture on CKD, a CKD reference card, academic detailing (residents only), and access to the CKD registry.
Active Comparator: Education only
Providers in the education only arm will receive a CKD lecture and be given a CKD reference card.
Behavioral: Education only
The education will consist of a lecture and distribution of a CKD reference card.
- PTH (Parathyroid Hormone) Adherence [ Time Frame: One year ]Probability for having a PTH measured during the study period comparing intervention vs control clinic during the study period as estimated by Generalized Estimating Equation (determines probability, not proportion). Participants assigned 1 if PTH was measured and 0 if PTH was not measured during the study period.
- Last Clinic BP <130/80 mmHg [ Time Frame: One year ]Probability of last Clinic BP <130/80 mmHg Comparing Intervention vs Control Clinic During the Study Period as estimated using Generalized Estimating Equation.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00921687
|United States, Ohio|
|Louis Stokes Cleveland Veterans Affairs Medical Center|
|Cleveland, Ohio, United States|
|Principal Investigator:||Paul E Drawz, MD, MHS, MS||Louis Stokes VA Medical Center|